Mast Therapeutics, Inc. (MSTX)

[Bx3]

Point being, BB sees GOOD reason to be in MSTX with a respectable number of shares. You'd have to assess the technical successes of every one of those tutes that altered share counts, in THIS quarter, in either, EITHER, either direction, to see how they stack up in overall 2-8 year selection/success rate against BB. Then you get a true handle on this quarter's movement. Not everyone appreciates what BB brings to the table or what that statement means to the biotech investor, who weighs that as a gold standard of biotech-technical knowledge and investigation. Simple difference of opinion. Not worth the time to discuss it. We'll see when this all shakes out. Until then, its all speculation, even BB's speculation. But who has the more educated guess? My bets on BB because I don't have access to all the tools and experience and technical capability they have. And I am enjoying things, possibly from a different perspective than yours, Pray. GLTA, All stated is IMO.